Free Lance Journalist Wants CPP stories

Free Lance Journalist Wants CPP stories

Bill Myers is putting together a proposal for editors of mass media in which his work has appeared.  To support a future series of articles, he wants to talk with patients or caregivers of patients
       (a) whose doctors have told them that they must taper down on opioid therapy that has been effective in maintaining their quality of life, to meet “CDC Standards” or local State guidelines,
       (b) whose doctors have left pain management practice citing fear for losing their medical license and livelihood if they continue to prescribe, or
       (c) who have been denied or had delays in renewal of a prescription by pharmacist who felt “uncomfortable” with the dose prescribed by their doctors.  If you’ve been denied renewal based on chain pharmacy “policy”, this may be particularly useful to share.
If you are in one of these categories and feel comfortable in talking with a journalist, then please feel free to correspond directly with Bill  at myers101@outlook.com. Send him your name, the area of the US where you live, and a contact email or phone number where you can be reached.  Don’t send him your entire life story.  Just contact data and maybe a few lines.  We don’t want to drown the man. 

Arcsology is Looking for Some Help 

Arcsology is Looking for Some Help 

Arcsology is a non profit organization (pending 501c3) made up of volunteer patients, clinicians and researchers dedicated to preventing and treating arachnoiditis and diseases of the arachnoid mater.

They  are recruiting new members to fulfill a few key roles. Below is the list of needed expertise. Please share on your Facebook timeline and to other groups, and forward to family, friends, and anyone inside or outside the arcs community!

Anyone interested in volunteering their time to help this organization succeed, please submit your resume or professional bio to:

info@arcsology.org

Needed Expertise:

Grant writer
Fundraising consultant/donor professional
Marketing/Media/Public relations professional
Psychologist/ mental health counselor or related professional
Website-word press builder and/or UX (user experience) professional
Healthcare professional blogger or writer
Professional writer/editor
Professional project manager
Attorney- licensed
Paralegal
Advanced practice clinicians: physicians, nurses practitioners, physician assistants.

 

Fentanyl overdose deaths in the U.S. have been doubling every year

Fentanyl overdose deaths in the U.S. have been doubling every year

https://www.orlandosentinel.com/news/space/go-for-launch/la-sci-sn-fentanyl-overdose-deaths-skyrocketing-20190320-story.html

If you want to know what it means for something to grow exponentially, consider the death toll of fentanyl.

This powerful synthetic opioid seemingly came out of nowhere and is now killing tens of thousands of Americans each year.

A new report from the Centers for Disease Control and Prevention details the meteoric rise of a drug that was first approved by the Food and Drug Administration back in 1968. It shows that fentanyl’s role as a driver of the opioid epidemic can be traced to late 2013.

Researchers from the CDC’s National Center for Health Statistics tallied the lives claimed by fentanyl between 2011 and 2016.

The figures were drawn from death records produced by coroners and medical examiners throughout the country. And while some of these officials were slow to recognize the new threat, the CDC researchers accounted for the fact that as the scourge spread, coroners and medical examiners became more likely to notice when fentanyl played a role in a person’s death.

Altogether, the records revealed that more than 36,000 Americans died with fentanyl in their systems during the study period. The majority of those deaths — 18,335 — occurred in 2016 alone.

 

The CDC experts used those figures to calculate annual death rates for overdoses involving fentanyl. After adjusting for age, they found that it is indeed growing exponentially — doubling every year.

In 2011 and 2012, there were 0.5 drug overdose deaths involving fentanyl for every 100,000 Americans. After that, the death rate began its precipitous climb.

Between 2013 and 2014, it jumped from 0.6 to 1.3 deaths per 100,000 Americans. In 2015, it climbed to 2.6 deaths per 100,000. And by 2016, there were 5.9 fentanyl-related deaths for every 100,000 Americans.

Fentanyl is anywhere from 50 to 100 times more powerful than morphine. When taken in uncontrolled concentrations by unsuspecting users, or by users whose opioid tolerance has not been heightened by long-term use, the drug is more likely even than prescription opioids to suppress respiration and cause death.

If you’re worried about prescription opioids, you should be really scared of fentanyl »

China’s 160,000 chemical and pharmaceutical manufacturers are among the major suppliers of illicit fentanyl, according to testimony presented last summer by Paul E. Knierim of the Drug Enforcement Administration to a House of Representatives subcommittee on global health.

To feed a growing population of Americans with addiction, these Chinese firms are shipping their product directly to the United States, and sometimes to cartels in Mexico, Canada and the Caribbean. Once in the Western Hemisphere, these chemicals are combined with heroin, cocaine and other drugs, and often pressed into counterfeit pills to be sold online or on the street as prescription opioids.

The result is as profitable as it is deadly.

Knierim, the deputy chief of operations for the DEA’s Office of Global Enforcement, told lawmakers that because fentanyl is so powerful and can boost the potency of so many illicit drugs, a single kilogram purchased in China for $3,000 to $5,000 “can generate upwards of $1.5 million in revenue on the illicit market with the potential of being lethal for 500,000 people.”

The new CDC report shows that fentanyl’s claim on female lives has risen sharply, but the toll among men is far more pronounced.

The rate of fatal overdoses involving fentanyl also increased exponentially for Americans of nearly all ages. But by 2014, young adults between the ages of 25 and 34 had both the highest rate of fatal fentanyl overdoses and the steepest rise in those deaths.

 

 

 

The epidemic of fentanyl deaths has ravaged New England, roared down the Atlantic Coast to Virginia, turned inland to the coalfields and hollows of West Virginia, and spread across the Rust Belt and the Upper Midwest. Fentanyl deaths were also on the rise from Arkansas to Alaska and across the American West, though in those areas they increased much more slowly.

Some experts believe the death rate will soon begin to rise more slowly in places like Massachusetts, where fentanyl gained an early and especially deadly foothold. However, they say the West has not yet seen the peak of this spreading epidemic.

The new report also documents a shift that had become evident to emergency responders and public health authorities by 2016: While death rates from prescription opioids and illicit synthetic opioids have been highest among rural white Americans, the expansion of an illegal market is creating new communities of users in urban centers, and among minorities.

Indeed, between 2011 and 2016, the rate of fatal fentanyl overdoses grew fastest among African Americans and Latinos.

In scathing ruling, judge rips insurer for putting ‘bottom line’ over patients’ health

In scathing ruling, judge rips insurer for putting ‘bottom line’ over patients’ health

https://www.cnn.com/2019/03/06/health/unitedhealthcare-ruling-mental-health-treatment/

In a scathing decision, a federal judge blasted a subsidiary of the nation’s largest insurance company for focusing on the “bottom line as much or more” than patients’ health, saying the insurer illegally denied treatment to thousands of people. The judge also slammed the company’s medical directors for being “deceptive” under oath.

US Chief Magistrate Judge Joseph Spero issued his decision Tuesday against United Behavioral Health, a unit of UnitedHealthcare, saying the insurer created internal policies that effectively discriminated against those seeking mental health and substance abuse treatment.
“It is well-established that effective treatment of mental health and substance use disorders includes treatment aimed at preventing relapse or deterioration of the patient’s condition and maintaining the patient’s level of functioning. UBH Guidelines deviate from that standard,” Spero said.
Legal observers called the decision one of the most important and most thorough rulings ever issued against an insurance company, at the federal level, on mental health issues.
Patrick Kennedy, the former US representative from Rhode Island who has long championed mental health issues, called the ruling “breathtaking” in its scope. For the mental health community, he equated it to the landmark 1954 Supreme Court decision that found racial segregation in public schools unconstitutional.
“This ruling is the Brown v. Board of Education for the mental health movement,” Kennedy said. “The insurance industry is hellbent on violating the federal law, and they’re doing so with impunity. Now, we have a federal court specifically and forensically breaking down how they get around the federal law.”
The class-action suit was brought on behalf of more than 50,000 people denied coverage by United Behavioral Health, the country’s largest managed behavioral health care organization.
Spero took more than a year to issue his 106-page decision. In addition to finding federal violations, Spero ruled that United Behavioral Health violated state laws in Illinois, Connecticut, Rhode Island and Texas.
The judge blasted United Behavioral Health’s medical directors and other expert witnesses who set the company’s policies — naming each one before shredding them as not credible and discounting their testimony.
“UBH’s experts, on the other hand, had serious credibility problems,” Spero wrote. “The Court found that with respect to a significant portion of their testimony each of them was evasive — and even deceptive — in their answers when confronted with contrary evidence.”
He said one board-certified psychiatrist and senior medical director, whose duties included supervising and training United Behavioral Health care advocacy clinicians, “was not always credible because in several instances he ignored the plain meaning of the words used in the Guidelines.”
Another United Behavioral Health expert whose duties included drafting coverage determination guidelines, the judge said, implemented a “model that keeps benefit expenses down by placing a heavy emphasis on crisis stabilization and an insufficient emphasis on the effective treatment of co-occurring and chronic conditions.”
The judge said such decisions had real impacts on patients because United Behavioral Health ignored “effective treatment of members’ underlying condition” and that “UBH knowingly and purposefully drafted its Guidelines to limit coverage to acute signs and symptoms.”
“Research has demonstrated that patients with mental health and substance use disorders who receive treatment at a lower level of care than is clinically appropriate face worse outcomes than those who are treated at the appropriate level of care,” Spero said in his ruling.
He concluded by saying one of the driving factors for such policy decisions was the company’s profit motivations: “Finally, the evidence at trial established that the emphasis on cost-cutting that was embedded in UBH’s Guideline development process actually tainted the process, causing UBH to make decisions about Guidelines based as much or more on its own bottom line as on the interests of the plan members.”
The ruling was issued in the US District Court for the Northern District of California. It will now move to a remedy phase in which the judge is to determine how the insurer should be punished.
Brian Hufford, one of the lead attorneys for the plaintiffs, said the case peeled back the layers of coverage decisions made by insurers that most policy holders don’t even know happen behind the scenes. He said the judge’s decision highlighted the fact United Behavioral Health was “making decisions that are influenced by their monetary concerns and what profits they can make.”
“This case involved coverage of benefits for the most vulnerable population — people who suffer from mental illness and substance abuse,” Hufford said. “Historically insurance companies have been able to hide that conduct and save money by denying treatment to these people in need.”
Meiram Bendat, an attorney and psychotherapist with the law firm Psych-Appeal who uncovered the guideline flaws, said the ruling was “vindication of what patients, providers, and the plaintiffs have been telling UBH for years — that the nation’s largest mental health insurer has been denying access to care on the false premise that ‘crisis’ should be the litmus test for coverage.”
UnitedHealthcare took issue with the judge’s comments about its medical directors, saying they “followed nationally accepted standards in reviewing these requests.”
“We look forward to demonstrating in the next phase of this case how our members received appropriate care,” UnitedHealthcare said in a written statement. “We remain committed to providing our members with access to the right care for the treatment of mental health conditions and substance use disorders.”
The National Alliance on Mental Illness, or NAMI, the nation’s largest advocacy group for the mentally ill, hailed the decision.
“This is a day NAMI has long awaited,” said Angela Kimball, NAMI’s national director of advocacy and public policy. “For decades, people with mental health conditions have experienced really horrific discrimination at the hands of health insurance plans. They routinely deny mental health care and often with tragic outcomes.”
She added, “This is absolutely an incredibly important decision.”
Speaking to CNN by phone, Kennedy called the judge’s ruling “scathing and breathtaking at the same time. I think, frankly, it can be used to understand how all the insurance companies are doing this.”
Get CNN Health’s weekly newsletter

Sign up here to get The Results Are In with Dr. Sanjay Gupta every Tuesday from the CNN Health team.

“Given the fact United is the largest insurer in the country, this is a very disturbing decision, and it has implications for United that they really haven’t come to grips with.”
He said that the decision is made even more important because it comes at a time when life expectancy in America has been going down because of a “public health crisis in mental health and addiction.”
“The notion that the largest insurer in the nation is denying care for a set of illnesses that is the driving reason we have higher death rates in this country,” Kennedy said, “you can’t make this stuff up.”

FDA: Pain Patients Dependent On Opioids Are Not Addicted

FDA: Pain Patients Dependent On Opioids Are Not Addicted

www.painnewsnetwork.org/stories/2019/2/6/fda-patients-dependent-on-opioids-are-not-addicted#.XJN0oMjDsMk.facebook=

The U.S. Food and Drug Administration has released new guidance to drug makers to streamline the development of buprenorphine products to treat opioid addiction. Commonly known by the brand name Suboxone, buprenorphine has long dominated the market for addiction treatment.

Of importance to pain patients is a statement about the guideline by FDA commissioner Scott Gottlieb, MD, that seeks to clarify the difference between opioid addiction and patients who need opioids for pain relief.

Gootlieb said there is still stigma and misunderstanding – even in the medical and addiction fields – about the difference between opioid addiction and dependence.

“Because of the biology of the human body, everyone who uses a meaningful dose of opioids for a modest length of time develops a physical dependence. This means that there are withdrawal symptoms after the use stops,” Gottlieb said. “A physical dependence to an opioid drug is very different than being addicted to such a medication.

bigstock-Addiction-Diagnosis-Medical-C-120768788.jpg

“Addiction requires the continued use of opioids despite harmful consequences on someone’s life. Addiction involves a psychological preoccupation to obtain and use opioids above and beyond a physical dependence. But someone who is physically dependent on opioids as a result of the treatment of pain but who is not craving the drugs is not addicted.”

“Someone who is physically dependent on opioids as a result of the treatment of pain but who is not craving the drugs is not addicted.”

— Dr. Scott Gottlieb, FDA Commissioner

In recent years new and generic formulations of buprenorphine have been released in tablets, sublingual films, injections and implants, and the FDA is trying to promote the development of more of them.

The guidance released by the agency basically tells drug makers they may be able to submit new drug applications for buprenorphine products without conducting the safety and efficacy trials that are usually required for other medications.

“The guidance we’re finalizing today is one of the many steps we’re taking to help advance the development of new treatments for opioid use disorder, and promote novel formulations or delivery mechanisms of existing drugs to better tailor available medicines to individuals’ needs,” Gottlieb said. “Our goal is to advance the development of new and better ways of treating opioid use disorder to help more Americans access successful treatments.”

There are currently only three drugs approved by the FDA for medication-assisted treatment (MAT) – buprenorphine, methadone and naltrexone. Physicians wishing to prescribe buprenorphine to patients must have a special certification from the DEA and are limited in the number of patients they can treat.

Buprenorphine is an opioid that is also used to treat pain. When combined with naloxone, buprenorphine reduces cravings for opioids and lowers the risk of abuse.

Some addicts have discovered that buprenorphine can also be used to get high or to ease their withdrawal pain from heroin and other opioids. Buprenorphine is such a popular street drug that the National Forensic Laboratory Information System ranked buprenorphine as the third most diverted opioid medication in the U.S. in 2014. 

A patient’s opposition to the anti-opioid movement

A patient’s opposition to the anti-opioid movement

www.kevinmd.com/blog/2019/03/a-patients-opposition-to-the-anti-opioid-movement.html

I recently read an article — “California Doctors Alarmed As State Links Their Opioid Prescriptions to Deaths” — that infuriates and frightens me I’m furious that doctors are being persecuted for opioid prescriptions written years ago, and frightened that my doctor here in California may be pressured to stop prescribing them for my painful genetic disorder (Ehlers-Danlos).

Twenty-six states have already implemented arbitrary restrictions on our appropriately prescribed opioids, but the California medical board’s project is even more of a nightmare:

1. Comb through the state’s PDMP for the last three years to find links from people who recently died from an overdose of illegal drugs to a doctor who prescribed them opioids for any reason at any time during the last three years.

2. Then review the doctor’s records for this patient and, if the CA medical board doesn’t agree with some aspect of this long-ago prescription, threaten the doctor with future prosecution.

3. In the meantime, demand the doctor produce a “written summary of the care he had provided” (justification) due in only two weeks and fine him $1,000 each day he’s late with his report.

This certainly makes me better understand why doctors are so afraid to prescribe opioids, even when patients are suffering from incurable and painful conditions. I can’t imagine how I’d have reacted upon receiving such a career-threatening and legally intimidating letter while I was still working.

The idea of a “standard dose limit” for a medication like opioids is absurd. It’s like setting a standard cooking time for a roast without specifying the weight of the meat (amount of pain) or temperature of the oven (individual’s ability to metabolize opioids).

In its own guideline from 2013, the medical board advised that “for certain types of pain, opioids were the cornerstone of treatment and should be pursued vigorously.”

This is, of course, still the truth for intractable pain that cannot otherwise be relieved, like from sickle cell disease or my own connective tissue disorder.

I’ve heard from so many other pain patients these days that their doctors only initiated opioid therapy as a “last resort” after many non-opioid treatments were tried and failed and then just for patients for whose pain these medications are effective. Even so, opioids are usually only one of multiple pain management strategies a patient will use.

The CA medical board seems to suspect doctors of negligence if they didn’t perform a complete history, physical exam or repeated testing before each 30-day prescription, even when the same dose of the same pain medication has been prescribed for the same intractable pain condition for years.

This is no different than how so many other drugs are prescribed for ongoing conditions, like high blood pressure, high cholesterol, or depression. Especially when we’ve been seeing the same doctor for years, such repetitive documentation of the obvious and unchanging seems a waste of time.

Like most chronic conditions, chronic pain rarely improves and usually worsens with age. Once the pain has been investigated, sometimes diagnosed but often not, and the medically appropriate decision has been made to start opioid therapy, the necessary dose will rarely decrease and can be expected to continue forever.

That sounds crazy to people who don’t understand what a positive difference opioids can make for us, how they are literally life-saving for someone like me who faces a lifetime of unrelenting pain. For anyone else but the bureaucrats trawling through long-ago prescription records, the reasons for an ongoing opioid prescription should be obvious: unresolved pain.

The article quotes, “But it’s unclear if the overall effect of the project will be good for patients.”

No, it’s not unclear at all: forcing doctors to reduce the dose of opioids a patient is prescribed without a medical reason is always bad for patients. I can’t understand how mandated changes in medication regimes that are made against a doctor’s judgment can possibly be imagined to benefit patients.

The CDC’s opioid prescribing guideline is intended only for primary care physicians, not pain specialists, and for patients who haven’t already been taking them for years and decades, like I have. Yet, these caveats are ignored as anti-opioid advocates rush to make the guideline’s suggested opioid dose risk boundaries (at 50 and 90 MME) into absolute limits for every patient in every situation.

I don’t believe the current punitive policies were either unforeseeable or unintended when the CDC guideline authors chose to quantify that which is not quantifiable, namely chronic pain and its relief. Universally mandated dose limits ignore the complexity of patients, our genetics, body chemistry, mental state, and lifestyle, to focus only on a single number.

The amount of pain relief achieved by a specific opioid, at a specific dose, at a specific time, for a specific patient can vary by a factor of 10 or more: some need only 30 MME per day, others may need 300 and even up to 3,000 MME; I know pain patients at both extremes.

Even worse, these dose limits on pain relief are targeting the wrong substance and the wrong people. The government’s own data shows that the majority of “opioid” overdoses are from combinations of illicit street drugs, not from opioids prescribed to pain patients.

Trying to stem illicit opioid overdose deaths by mandating restrictions on opioids for patients in pain is only a cruel experiment fueled by ignorance and fear.

Angelika Byczkowski is a patient with Ehlers-Danlos syndrome who blogs at EDS Info.

Coalition of 50 states Pain Advocacy

From: TameraLynn Stewart
Sent: Thursday, March 21, 2019 12:20 AM
To: Steve Ariens
Subject: Federal health staffer gave us a plan!

 

Hi Steve! This is Tamera Stewart. As Valorie Hawk is stepping back to focus on her health and her family, I will be stepping into a more active roll. We have been given step by step instructions directly from an experienced Health Staffer for a Federal Rep that he believes will be our best chance to make a huge difference in the next 60 days, but we have to act fast! Here is step one, and I have the rest to put out over the weekend, but was wondering if you could help by sharing this also? This is what I am about to put on the page and into the groups.

A Congressman’s Health Staff gave us a plan to get our issue into the hands and minds of EVERY federal Representative and Senator in 5 weeks time, so here is Step1:

 

March 21 & March 22

 

Call the LOCAL office for your 3 congressmen (1 rep & 2 senators) and say something like:

 

My name is _____________ . I am a volunteer with the Coalition of 50 States Pain Advocacy Groups, and I am concerned about a renewed push to limit the abilities of our providers to prescribe pain medication to patients based on their individual need. This comes at a time when many unintended consequences of the CDC Guidelines for Responsible Opioid Prescribing are coming to light and some states are even rolling back their restrictive prescribing laws due to deaths and harms to patients.

I would like to meet with Congressman/woman or Senator _______________ when he/she is in the district/state next month while Congress is on their April break. It will likely be a small group of us from the district consisting of pain patients with varying conditions, care givers and/or advocates, and possibly medical professionals (possibly by skype or phone conference) if their schedule allows.

 

Then listen to what they have to say. If they ask you to email them with something formally requesting the meeting, no problem, we have that covered just get their email.  Some will ask that you meet with their field representative or liaison before the Congressman, and that is great; sometimes that is a better place to start anyway!

 

Basically follow their directions to set an appointment with SOMEONE! I personally have had good luck asking them if we can have 10-15 minutes before or after an already scheduled public event or townhall. Then you get to meet with them AND go to the event and really be seen and heard!!!

 

Main thing, if you have ANY questions, please PM me (Tamera Stewart) or the Facebook page (@c50advocacy) and ask! We will help find others in your area and have medical professionals ready to either meet with you or call/skype in to provide the professional side of it. The papers are ready, we have info that can be customized into a packet to fit your exact needs in minutes, including specific solutions that they can put into action! All you have to know is you and your story and be willing to work a little bit to prepare and then share!  THEY WILL MEET WITH YOU, BE CONFIDENT AND POLITE!

 

To find your federal Senators and Reps, and for step by step instructions, go to:

https://painadvocate.org/find-your-reps%2Fsenators

 

This could be a huge opportunity, we need EVERYONE to make these calls/requests to make sure they know how many of us are speaking out! to find your federal Senators and Reps, and for step by step instructions!

 

Unintended Consequences of Opioid Crackdown

Yesterday Kaiser Permanente signed my death warrant

I was left at an 8 due to a forced step down by Kaiser Permanente (due to the recs pre 2016.. Were those 2014? It’s hard for me to access memories anymore. The pain is too loud.) in Southern California. I had been at a daily pain level of 5-6 before the step down. Now, I am bedridden and have left the house once for anything but medical visits in four years. (We tried to go out for lunch on my birthday two years ago. It put me at a 9 for three days.) My pain controls my life. It is torture. And yes, I did file the motion to join California’s Starburst last month.

Yesterday Kaiser Permanente signed my death warrant.

They gave me a choice. I can either let them step me down or deal cold turkey with them stopping writing my pain prescriptions. I am barely holding on by a thread at an 8. Sooner or later at a pain level of 9, I will euthanize myself. I have started grieving my own death and prioritizing my books-to-be-read and movies-to-watch. Now I am waiting. I get to go until my next medication refill and then… Then.. Then I endure the painful horror as long as I can- and finally will love myself enough to let go via self euthanasia.

I promise, fellow pain sufferers, that I will not use opioids in my euthanasia. I will not be a statistic to use against you. The question is between an exit bag and helium or a severed carotid. (The exit bag is easier psychologically, but can be reversed-leaving brain damage. The severed carotid leaves you unconscious within 90 seconds, dead inside of five minutes and is absolutely sure, even if done in an emergency room. It is so screwed up that I had to research and learn that!) I promise I will send a snail- letter detailing my diagnosis (Fibromyalgia and Ehlers–Danlos syndrome), my attempts to control pain over the past 20 years, the horror of being stepped down, the torturous level of pain I have endured and my final exit to ABC, NBC, CBS and fox locally, in my state capital of Sacramento and Washington DC. I will also send it to my mayor, governor, state and federal representatives, the director of the CDC, the White House and to our president himself. I will post it on Facebook (who will probably delete it) and email it to Robert Rose. (I have already started it, as I am only sure of the next month.) I will do my best for those of you left. I will make sure everyone knows that I didn’t want to die, but was forced to it due to torturous pain after losing my pain control. I keep telling myself that I should be relieved. My suffering is almost over. Maybe I will even believe it by the end. I doubt it though. I don’t want to die,

This is NOT the first that I have heard from a Kaiser Permanente pt that they are being forced to reduce their opiate pain therapy until the pt is being forced to live/exist in a torturous level of pain.  This is the WORSE that I have seen come my from one of their pts. One has to wonder how many thousands of other Kaiser pts are in the same boat and/or have already committed suicide or died from “natural causes” because of their under/untreated pain. Below is a list of bodily functions that are adversely impacted by under/untreated pain.  Could pts that have had their pain meds reduced could end up dying from “natural causes” but in reality it is from under/untreated pain and the consequences of doing this.

I guess that the employee/prescribers working for Kaiser have abandoned their oath to “DO NOT HARM” for keeping their PAYCHECK going forward.

 

 

JUMPING TO CONCLUSIONS AT CVS ?

JUMPING TO CONCLUSIONS AT CVS ?

Image result for clipart jumping to conclusion